Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexMale
Age18+
SponsorHenry Ford Health System

About this trial

The investigators are testing the efficacy of a new, FDA-approved bioinductive patch in lateral epicondylitis (tennis elbow) patients. A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomize into one of two groups: control and investigational. Patients in the "control group" will receive the normal surgery for patients who do not respond to physical therapy, lifestyle changes, and anti-inflammatory treatment. Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of lateral epicondylitis (tennis elbow) that has failed conservative treatment (Physical therapy, activity change, anti-inflammatory treatment.

Disqualifiers

Previous surgery on the currently-affected elbow.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Smith & Nephew Bioinductive Implant

    Biological/Vaccine

    A bioinductive implant that is supposed to foster healthy tendon regrowth after surgery.

  • Lateral Epicondylectomy

    Procedure/Surgery

    This procedure is the standard of care for lateral epicondylitis patients who fail conservative treatment options.

  • Ultrasound Imaging

    Radiation

    An ultrasound will be performed on each patient both preoperatively and at 6 months.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: ControlActive comparator 2 interventions
Group B: ExperimentalExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

PROMIS CAT Scores

A short 5 minute survey asking questions about physical function, pain, and mental health

Time frame
Preoperative to 1 year postoperative
2

Visual Analog Scale (VAS) for Pain

Traditional 1 to 10, subjective rating of pain the patient is experiencing

Time frame
Preoperative to 1 year postoperative
3

Range of Motion

Standard range of motion values collected by the surgeon during preoperative and followup visits

Time frame
Preoperative to 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Henry Ford Health System

Lead sponsor

Smith & Nephew, Inc.

Collaborator